Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-05

Clinical Trial Update: Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a four-modality bladder-preservation strategy (TURBT with chemo/immunotherapy, radiation, and maintenance immunotherapy) versus watchfu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Muscle-invasive Bladder Cancer | Phase 2 | Status: NOT_YET_RECRUITING